Pathfinders in Biopharma

Biotech and Big Pharma: Blueprint for Successful Partnership


Listen Later

As biotech firms and large pharma companies find new synergies to bring new treatments to market together, Noël Brown, Managing Director and Head of US Biotechnology Investment Banking at RBC Capital Markets, interviews pharma industry veteran, now Biopharma Managing Director, Greg Wiederrecht on what it takes to ensure a strategic partnership not only survives, but thrives.

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,647 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,714 Listeners

Motley Fool Money by The Motley Fool

Motley Fool Money

3,210 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,071 Listeners

Exchanges by Goldman Sachs

Exchanges

965 Listeners

Odd Lots by Bloomberg

Odd Lots

1,918 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

323 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,018 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,284 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,941 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

32 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

40 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

17 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

3 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

18 Listeners

The Markets by Goldman Sachs

The Markets

69 Listeners

The Top Line by Fierce Life Sciences

The Top Line

13 Listeners